Skip to section navigation
Skip to page content

Health, Wellbeing, and Public Health

Helping clients understand how a range of conditions and lifestyle choices impact public health, as well as how sustained behaviour change can improve health outcomes and reduce health inequalities

Research, commentary, and events

Project
The impact of respiratory syncytial virus on the NHS, society and economy in the UK
Researchers estimate the total economic impact of respiratory syncytial virus (RSV) to be around £80 million each year, based on a rapid evidence assessment to model the disease's wider societal and economic burden in the UK.
31 May 2022
Project
The indirect economic and societal burden of seasonal influenza on the UK
In 2019, absenteeism and presenteeism cost the UK economy almost £92 billion because of ill-health, but the economic burden specific to seasonal influenza is not well understood. Researchers are exploring the indirect economic and societal burden of seasonal influenza, including its effects on the UK healthcare system.
29 Mar 2022
Project
The socioeconomic impact of poor indoor climate on health and life satisfaction
Poor indoor climate can result in a higher risk of health and wellbeing disorders, especially in children, the elderly and those with existing health conditions. Exposure of Europeans to damp, mould, and insufficient daylight in residential buildings could cost €53 billion over the next 30 years.
22 Mar 2022
Project
Understanding industry contributions to the fight against antimicrobial resistance
The AMR Industry Alliance brings together over 100 biotechnology, diagnostic, generics and research-based biopharmaceutical companies and trade associations in the fight against AMR. RAND Europe assessed the progress of AMRIA members in contributing to tackling AMR and found they are making a difference on diverse fronts.
01 Feb 2022
Project
Assessing the landscape of longitudinal data collection related to gambling
Researchers assessed the feasibility for expanding longitudinal data collection on gambling in the UK. They provide six distinct options, each with their own strengths and drawbacks, for consideration by the charity Action Against Gambling Harms.
25 Jan 2022
Project
Smoke-free environments and the advertising of tobacco and related products
Although EU member states are generally compliant with national rules on smoke-free environments and tobacco-related advertising, some areas require closer scrutiny, including protecting children from the harms of smoking.
04 Jan 2022
Project
Assessing EHR for infectious disease surveillance, prevention and control
Electronic health records (EHR) data could greatly help infectious disease surveillance, but their use varies across Europe. Researchers mapped EHR use to assess the feasibility of using EHR data for infectious disease surveillance.
10 Dec 2021
Commentary
Green Light for Cannabis Legalisation in Germany Is Not a Clear-Cut Decision
The new “traffic light” coalition in Germany recently agreed to regulate the sale of cannabis to adults for recreational purposes in licensed shops. International experience has shown that great care is needed in how cannabis policy is shaped.
06 Dec 2021
Project
Assessing POCT for infectious disease surveillance, prevention and control
Researchers examined the availability of point-of-care testing (POCT) devices to diagnose 56 communicable diseases and related health issues under EU surveillance — not including COVID-19 — and mapped trends in the use of POCT in Europe.
02 Dec 2021
Project
Making outcome-based payment a reality in the NHS: Phase 2
To prepare for the implementation of a pilot scheme to pay for cancer drugs based on achieved outcomes, researchers addressed issues identified in the first phase of research, such as the quality and completeness of real-world data on key patient outcomes.
23 Nov 2021
Project
The impact of antimicrobial resistance on modern medicine
Most research on antimicrobial resistance (AMR) focuses on its effects on communicable diseases. But AMR can result in a wide variety of negative outcomes for patients with non-communicable health conditions and/or who are exposed to certain healthcare services.
30 Sep 2021
Commentary
Australia Contained COVID-19 Early On. Can It Do the Same with Synthetic Opioids?
Australia is at risk of a fentanyl problem, but it is better prepared than North America. If the country can make the same kind of concerted effort it did to keep COVID-19 at bay, that could save thousands of lives.
30 Apr 2021
Commentary
Equal, Rapid Access to Vaccines Is More Important Than Ever as New COVID-19 Variants Emerge
Vaccine nationalism could prolong the pandemic and lead to preventable deaths. If some countries don't receive timely access to vaccines, then the virus will continue to spread in some populations, mutate further, and potentially render existing vaccines less effective.
09 Feb 2021
Project
Evaluation design for multiple long-term health conditions programme
Complex evaluations at multiple levels are gathering evidence for Guy’s and St Thomas’ Charity on societal determinants of health such as housing, debt, racism and labour markets. The findings will inform policy to help those most at risk of developing long-term conditions.
29 Jan 2021
Project
COVID-19 and the cost of vaccine nationalism
Without a vaccine, the worldwide economic impact of COVID-19 could be $3.4 trillion a year. But even when a vaccine is available, an unequal allocation of COVID-19 vaccines could cost the global economy up to $1.2 trillion a year in GDP.
28 Oct 2020

Page 1 of 6
1
2
3
4
5
6
Next